Induction of p53‐mediated transcription and apoptosis by exportin‐1 ( XPO 1) inhibition in mantle cell lymphoma-Reference-Cited by-同舟云学术

Induction of p53‐mediated transcription and apoptosis by exportin‐1 ( XPO 1) inhibition in mantle cell lymphoma

Published:2014-06-03 Issue:7 Volume:105 Page:795-801
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yoshimura Mariko¹,Ishizawa Jo²,Ruvolo Vivian²,Dilip Archana²,Quintás‐Cardama Alfonso³,McDonnell Timothy J.⁴,Neelapu Sattva S.⁵,Kwak Larry W.⁵,Shacham Sharon⁶,Kauffman Michael⁶,Tabe Yoko⁷,Yokoo Masako¹,Kimura Shinya¹,Andreeff Michael²,Kojima Kensuke¹²

Affiliation:

1. Hematology Respiratory Medicine and Oncology Department of Medicine Saga University Saga Japan

2. Molecular Hematology and Therapy Department of Leukemia The University of Texas MD Anderson Cancer Center HoustonTexas

3. Department of LeukemiaThe University of Texas MD Anderson Cancer Center HoustonTexas

4. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston Texas

6. Karyopharm Therapeutics Boston Massachusetts USA

7. Department of Clinical Laboratory Medicine Juntendo University School of Medicine Tokyo Japan

Funder

National Institutes of Health

Fredrick B. Hagemeister Research Fund

Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan

Japan Leukemia Research Fund

Osaka Cancer Research Foundation

Paul and Mary Haas Chair in Genetics

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12430

Reference40 articles.

1. NESdb: a database of NES-containing CRM1 cargoes

2. Nuclear transport and cancer: from mechanism to intervention

3. Nuclear export of proteins and drug resistance in cancer

4. The expression of CRM1 is associated with prognosis in human osteosarcoma;Yao Y;Oncol Rep,2009

5. EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?;International Journal of Molecular Sciences;2024-06-01

2. Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial;European Journal of Haematology;2024-05

3. Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study);Life;2024-03-14

4. The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression;Scientific Reports;2023-10-29

5. Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures;Frontiers in Immunology;2023-10-02